2000
DOI: 10.1161/01.cir.102.19.2335
|View full text |Cite
|
Sign up to set email alerts
|

Chlamydia pneumoniae , Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults

Abstract: Background-Whether serological evidence of prior infection with Chlamydia pneumoniae, herpes simplex virus type 1 (HSV-1), and cytomegalovirus (CMV) is associated with myocardial infarction (MI) and coronary heart disease (CHD) death remains a source of controversy. Methods and Results-We conducted a nested case-control study among participants in the Cardiovascular Health Study, a cohort study of persons aged Ն65 years. Cases experienced an incident MI and CHD death (nϭ213). Control subjects were matched to c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
81
1
3

Year Published

2002
2002
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(87 citation statements)
references
References 41 publications
2
81
1
3
Order By: Relevance
“…13 In a case-control study of 213 elderly patients with a known myocardial infarction or coronary artery disease, CMV seropositivity was also not associated with mortality during a 2-year average follow-up period. 12 In this study, however, antibodies to herpes simplex type 1 and high titer antibodies to Chlamydia pneumoniae were independent risk factors for death.…”
Section: Articlecontrasting
confidence: 57%
See 1 more Smart Citation
“…13 In a case-control study of 213 elderly patients with a known myocardial infarction or coronary artery disease, CMV seropositivity was also not associated with mortality during a 2-year average follow-up period. 12 In this study, however, antibodies to herpes simplex type 1 and high titer antibodies to Chlamydia pneumoniae were independent risk factors for death.…”
Section: Articlecontrasting
confidence: 57%
“…9,10 Other studies have not confirmed an association between CMV infections and/or high antibody titers and coronary artery disease. [11][12][13] Although there is currently no licensed CMV vaccine, CMV is a vaccine preventable infection. 14 Current vaccine strategies contemplate immunizing women of child-bearing age and transplant recipients.…”
Section: Introductionmentioning
confidence: 99%
“…Seropositivity for CMV (or the level of CMV immunoglobulin G antibodies) has been reported to be associated with cardiovascular disease 30, 31. Furthermore, positive serology for HHV‐1 has been found to be associated with a higher risk of myocardial infarction or cardiovascular death 32, 33. In autopsies of aortic tissues that were identified histologically as atherosclerotic, DNA of HHV‐1, HHV‐4, and CMV were present more frequently than in nonatherosclerotic tissues 34, 35.…”
Section: Discussionmentioning
confidence: 99%
“…As such, the study provides a crucial link by which pathogens may contribute to atherogenesis. 25,34,35 …”
Section: Discussionmentioning
confidence: 99%